These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. Morrow P, Nakamura R, Schlaerth J, Gaddis O, Eddy G. Am J Obstet Gynecol; 1985 Apr 01; 151(7):906-14. PubMed ID: 2580438 [Abstract] [Full Text] [Related]
5. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands. Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP. Obstet Gynecol; 1983 Oct 01; 62(4):467-73. PubMed ID: 6888825 [Abstract] [Full Text] [Related]
7. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin. Kamariah K, Satgunasingam N, Nasri NM, Ng KY. Med J Malaysia; 1993 Mar 01; 48(1):40-5. PubMed ID: 7688063 [Abstract] [Full Text] [Related]
8. Natural history of partial molar pregnancy. Berkowitz RS, Goldstein DP, Bernstein MR. Obstet Gynecol; 1985 Nov 01; 66(5):677-81. PubMed ID: 2414703 [Abstract] [Full Text] [Related]
9. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia. Eysbouts Y, Brouwer R, Ottevanger P, Massuger L, Sweep F, Thomas C, van Herwaarden A. Int J Gynecol Cancer; 2017 Jun 01; 27(5):1035-1041. PubMed ID: 28498241 [Abstract] [Full Text] [Related]
11. Human chorionic gonadotropin levels in complete and partial hydatidiform moles and in nonmolar abortuses. Smith EB, Szulman AE, Hinshaw W, Tyrey L, Surti U, Hammond CB. Am J Obstet Gynecol; 1984 May 15; 149(2):129-32. PubMed ID: 6720790 [Abstract] [Full Text] [Related]
15. Serum relaxin in patients with hydatidiform mole. Seki K, Uesato T, Tabei T, Kato K. Obstet Gynecol; 1986 Mar 15; 67(3):381-3. PubMed ID: 3945450 [Abstract] [Full Text] [Related]
16. Relationship of prolactin and estradiol to human chorionic gonadotropin following molar gestation. Ho Yuen B. Am J Obstet Gynecol; 1983 Mar 01; 145(5):618-20. PubMed ID: 6681939 [Abstract] [Full Text] [Related]
17. Inhibin: a new circulating marker of hydatidiform mole? Yohkaichiya T, Fukaya T, Hoshiai H, Yajima A, de Kretser DM. BMJ; 1989 Jun 24; 298(6689):1684-6. PubMed ID: 2503176 [Abstract] [Full Text] [Related]
18. Serum estradiol-17beta and serum human chorionic gonadotropin in patients with hydatidiform moles. Dawood MY, Ratnam SS, Teoh ES. Am J Obstet Gynecol; 1974 Aug 01; 119(7):904-10. PubMed ID: 4366791 [No Abstract] [Full Text] [Related]
19. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy. Schlaerth JB, Morrow CP, Kletzky OA, Nalick RH, D'Ablaing GA. Obstet Gynecol; 1981 Oct 01; 58(4):478-82. PubMed ID: 7279342 [Abstract] [Full Text] [Related]
20. Endocrine control of the seasonal occurrence of ovulation in rhesus monkeys housed outdoors. Walker ML, Wilson ME, Gordon TP. Endocrinology; 1984 Apr 01; 114(4):1074-81. PubMed ID: 6423367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]